Cleared Traditional

INTERLINK(TM) BLUNT CANNULA, MODIFICATION (K911868) - FDA 510(k) Clearance

Class II General Hospital device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K911868 · Baxter Healthcare Corp · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1991
Decision
59d
Days
Class 2
Risk

K911868 is an FDA 510(k) clearance for the INTERLINK(TM) BLUNT CANNULA, MODIFICATION. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Baxter Healthcare Corp (Round Lake, US). The FDA issued a Cleared decision on June 24, 1991 after a review of 59 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Baxter Healthcare Corp devices

Submission Details

510(k) Number K911868 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 26, 1991
Decision Date June 24, 1991
Days to Decision 59 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
70d faster than avg
Panel avg: 129d · This submission: 59d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 207
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K911868.
8000 SERIES VOLUMETRIC PUMP SOLUTION SET
K914074 · Baxter Healthcare Corp · Oct 1991
3 PORT ADAPTER
K913627 · Baxter Healthcare Corp · Sep 1991
VOLUMETRIC PUMP SOLUTION SET MODIFIED CASSETTE
K912141 · Baxter Healthcare Corp · Sep 1991
B-D SAFETY-LOK(TM) I.V. NEEDLES
K911136 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Jun 1991
IN-LINE VIAL CONNECTION SITE
K900909 · Baxter Healthcare Corp · May 1990
AVI MODEL 2012, 1.2 MICRON FILTER IV ADMINISTRA.
K896161 · 3M Company · Jan 1990